Hancock-Jaffe Enters Into Joint Venture
- Share via
IRVINE — Hancock-Jaffe Laboratories, a developer of biological implants for the cardiovascular, orthopedic and plastic surgery markets, has entered into a joint-venture agreement with a Minnesota company.
St. Jude Medical Inc. of St. Paul made the announcement Monday, saying the deal will allow the companies to combine their research in developing a heart valve made from tissue rather than a non-biological material.
St. Jude spokesman Steve Schuster said that negotiations for the joint venture have been ongoing for the past several months and that the deal was signed Monday.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
